Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
4 Tampilan
administrator
07/30/23
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Menampilkan lebih banyak
Komentar Facebook
Tidak ada komentar yang ditemukan